- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Liver Disease Diagnosis and Treatment
- Medical and Agricultural Research Studies
- Liver Diseases and Immunity
- Health, psychology, and well-being
- Gastrointestinal motility and disorders
- Drug-Induced Hepatotoxicity and Protection
- Fusion and Plasma Physics Studies
- Diet, Metabolism, and Disease
S. M. Kirov Military Medical Academy
2019-2021
The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries world. Patients with comorbidity are most vulnerable group high risk adverse outcomes. problem managing these patients context requires comprehensive approach aimed both at optimal management self-isolated not visiting medical facilities, and comorbidities COVID-19. presented consensus covers two aspects cardiovascular disease, diabetes, chronic...
The presented clinical practice guidelines of the Gastroenterological Scientific Society Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during COVID-19 pandemic. were approved by XXIII Congress GSSR 22nd International Slavonic-Baltic Forum “St. Petersburg — Gastro-2020 ON-LINE” (St. Petersburg, June 11, 2020).
Frequent damage to the digestive system with a new coronavirus infection, as well its combination gastroenterological pathology complicates whole complex of therapeutic and diagnostic measures for such patients. Understanding problem is complicated by large number conflicting scientifi c data varying degrees evidence. The article describes mechanisms gastrointestinal tract (gastrointestinal tract) aff ection SARSCoV-2 — induction infl ammation violation permeability mucosa, changes in...
The presented clinical practice guidelines of the Gastroenterological Scientific Society Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during COVID-19 pandemic. were approved by XXIII Congress GSSR 22nd International Slavonic-Baltic Scientifi c Forum “St. Petersburg - Gastro-2020 ON-LINE” (St. Petersburg, June 11, 2020). Russian Medical Internal Medicine (RSMSIM) recommendations at XV National Medicine, NOGR on basis 1st edition, adopted Slavic-...
The occurrence of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease without cirrhosis is particular relevance view the increasing number patients, absence predictors development and its late diagnosis. article devoted to analysis pathogenetic aspects hepatic carcinogenesis participation bile acids intestinal microbiome promising directions early diagnosis possible prevention disease.
The presented study is devoted to one of the urgent problems conservative treatment chronic pancreatitis — relief painful abdominal and dyspeptic syndromes. Polymorphism etiopathogenetic variants formation pancreatic diseases naturally justifies need for complex therapy, including secretolytics, antispasmodics medications polyenzyme drugs. use Meteospasmyl in therapy effectively relieves pain dyspepsia, modifies composition intestinal microbiota improves quality life patients with pancreatitis.
.